<DOC>
	<DOCNO>NCT01852435</DOCNO>
	<brief_summary>The main purpose study evaluate safety efficacy R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 Treatment Diffuse Large B-cell lymphoma Follicular Lymphoma Grade 3B patient .</brief_summary>
	<brief_title>R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 Treatment Diffuse Large B-cell Lymphoma Follicular Lymphoma Grade 3B</brief_title>
	<detailed_description>The study aim evaluate safety efficacy R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 Treatment Diffuse Large B-cell lymphoma Follicular Lymphoma Grade 3B patient .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>1 . Histologically confirm de novo diffuse large Bcell lymphoma follicular lymphoma grade 3B 2 . Age &gt; =16 y.o. , &lt; =80 y.o . 3 . ECOG &lt; 3 4 . No past history malignancy 5 . Radiologically measurable disease , CT image screen show 2 clearly demarcated lesion large diameter &gt; 1.5 cm , 1 clearly demarcate lesion large diameter &gt; 2.0 cm . 6 . Life expectancy &gt; 6 month 7 . Informed consent 1 . Chemotherapy 2 . Bone marrow transplantation 3 . History malignancy 4 . Active infectious disease require general antibiotic , antifungal antivirus therapy 5 . Uncontrollable cardiocerebral vascular , coagulative , autoimmune , serious infectious disease 6 . Primary cutaneous , CNS , mediastinal DLBCL 7 . LVEFâ‰¤50 % 8 . Other uncontrollable medical condition may may interfere participation study 9 . Lab enrollment ( unless cause lymphoma ) Neutrophile &lt; 1.5*10^9/L Platelet &lt; 80*10^9/L Hemoglobulin &lt; 100g/L ALT AST &gt; 2*ULN , AKP bilirubin &gt; 1.5*ULN Creatinine &gt; 1.5*ULN 10 . Not able comply protocol mental unknown reason 11 . Pregnant lactation 12 . Active liver biliary disease 13 . If HbsAg positive , check HBV DNA , DNA positive patient enrol . If HBsAg negative HBcAb positive ( whatever HBsAb status ) , check HBV DNA , DNA positive patient enrol . 14 . HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>diffuse large B-cell lymphoma</keyword>
	<keyword>follicular lymphoma grade 3B</keyword>
</DOC>